Phio Pharmaceuticals (PHIO) Free Cash Flow (2016 - 2021)
Historic Free Cash Flow for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q4 2021 value amounting to -$2.5 million.
- Phio Pharmaceuticals' Free Cash Flow rose 583.08% to -$2.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.9 million, marking a year-over-year decrease of 3500.74%. This contributed to the annual value of -$7.1 million for FY2024, which is 3385.72% up from last year.
- Per Phio Pharmaceuticals' latest filing, its Free Cash Flow stood at -$2.5 million for Q4 2021, which was up 583.08% from -$2.9 million recorded in Q3 2021.
- Phio Pharmaceuticals' 5-year Free Cash Flow high stood at -$1.8 million for Q4 2018, and its period low was -$3.3 million during Q1 2021.
- Over the past 5 years, Phio Pharmaceuticals' median Free Cash Flow value was -$2.2 million (recorded in 2017), while the average stood at -$2.3 million.
- As far as peak fluctuations go, Phio Pharmaceuticals' Free Cash Flow skyrocketed by 3191.72% in 2018, and later tumbled by 6156.13% in 2021.
- Over the past 5 years, Phio Pharmaceuticals' Free Cash Flow (Quarter) stood at -$2.2 million in 2017, then rose by 20.45% to -$1.8 million in 2018, then tumbled by 45.12% to -$2.5 million in 2019, then dropped by 3.27% to -$2.6 million in 2020, then grew by 5.83% to -$2.5 million in 2021.
- Its Free Cash Flow stands at -$2.5 million for Q4 2021, versus -$2.9 million for Q3 2021 and -$3.3 million for Q2 2021.